Tumor-associated macrophages (TAMs) with an M2 phenotype have been associated not only with failure of anti PD-1/PD-L1 therapy (reviewed in [26]) but also with hyper-progressions in lung cancer patients. This evidence concerns the gene CD274 and lung carcinoma.